Abstract
The NOTCH signaling system regulates a variety of cellular processes during embryonic development and homeostasis maintenance in different tissues and contexts. Hence, dysregulation of NOTCH signaling is associated with a plethora of human cancers, and there have been multiple efforts to target key components of this pathway. In this review, we briefly highlight the latest research advances in understanding HES6, a poorly studied component of the NOTCH pathway. We summarize the role of HES6 in cancers with a focus on uveal melanoma. Finally, we discuss the ongoing efforts to target the NOTCH-HES6 axis in cancers.
Author supplied keywords
Cite
CITATION STYLE
Krossa, I., Strub, T., Martel, A., Nahon-Esteve, S., Lassalle, S., Hofman, P., … Bertolotto, C. (2022). Recent advances in understanding the role of HES6 in cancers. Theranostics. Ivyspring International Publisher. https://doi.org/10.7150/thno.72966
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.